Reliable set-up for in-loop 11C-carboxylations using Grignard reactions for the preparation of [carbonyl-11C]WAY-100635 and [11C]-(+)-PHNO  by Rami-Mark, Christina et al.
Applied Radiation and Isotopes 82 (2013) 75–80Contents lists available at ScienceDirectApplied Radiation and Isotopes0969-80
http://d
n Corr
Therapy
Guertel
E-mjournal homepage: www.elsevier.com/locate/apradisoReliable set-up for in-loop 11C-carboxylations using Grignard reactions
for the preparation of [carbonyl-11C]WAY-100635 and
[11C]-(+)-PHNO
Christina Rami-Mark a,b, Johanna Ungersboeck a,b, Daniela Haeusler a,c, Lukas Nics a,d,
Cecile Philippe a,c, Markus Mitterhauser a,c, Matthaeus Willeit e, Rupert Lanzenberger e,
Georgios Karanikas a, Wolfgang Wadsak a,b,n
a Radiochemistry and Biomarker Development Unit, Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine,
Medical University of Vienna, A-1090 Vienna, Austria
b Department of Inorganic Chemistry, University of Vienna, A-1090 Vienna, Austria
c Department of Pharmaceutical Technology and Biopharmaceuticals, University of Vienna, A-1090 Vienna, Austria
d Department of Nutritional Sciences, University of Vienna, A-1090 Vienna, Austria
e Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, AustriaH I G H L I G H T S Generalized method for in-loop 11C-carboxylations implemented.
 Grignard reactions successfully tested.
 First in-loop procedure for [11C]-(+)PHNO established.
 Satisfactory synthesis outcome for both [carbonyl-11C]WAY-100635 and [11C]-(+)PHNO.
 No distillation for puriﬁcation of intermediate required.a r t i c l e i n f o
Article history:
Received 1 August 2012
Received in revised form
22 July 2013
Accepted 25 July 2013
Available online 3 August 2013
Keywords:
Loop method
Grignard reaction
Carbon-11
[11C]-(+)-PHNO
[carbonyl-11C] WAY 10063543 & 2013 The Authors. Published by Elsevie
x.doi.org/10.1016/j.apradiso.2013.07.023
esponding author at: Department of Biomedic
, Division of Nuclear Medicine, Medical Univ
18-20, A-1090 Vienna, Austria. Tel.: +43 1 40
ail address: wolfgang.wadsak@meduniwien.aca b s t r a c t
Aim of this work was the implementation of a generalized in-loop synthesis for 11C-carboxylations and
subsequent 11C-acylations on the TRACERlab FxC Pro platform. The set-up was tested using [carbonyl-11C]
WAY-100635 and, for the ﬁrst time, [11C]-(+)-PHNO. Its general applicability could be demonstrated and
both [carbonyl-11C]WAY-100635 and [11C]-(+)-PHNO were prepared with high reliability and satisfying
outcome.
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Open access under CC BY licencarbon-11 labeled PET-tracers (Arai et al., 2009; Luthra et al., 1990;
Matarrese et al., 2002; McCarron et al., 1996; Zhang et al., 2006).
These carbon-11 synthons are prepared using the reaction of [11C]
CO2 ([11C]carbon dioxide) and various organo-magnesium halides
(so called Grignard reagents (Walborsky, 1990)) for further acyla-
tion reactions leading to demanded radiotracer compounds.
One of these compounds is the well-known PET-tracer, [carbonyl-
11C]WAY-100635, which is a highly potent antagonist at serotonin-1A
receptor (5HT1A) (Andree et al., 2000; Pike et al., 1996). Since the imple
mentation of Grignard reactions is a challenging task for radio-che-
mists, many set-ups and procedures have been reported, either using a
so called “wet” reaction (Hwang et.al., 1999; Krasikova et al., 2009;
Pike et al., 1996) or using an in-loop-method (Krasikova et al., 2003;se.
Table 1
Comparison of reaction parameters for the synthesis of [11C]-(+)-PHNO.
Synthesis Wilson et al. (2005) Plisson et al. (2012) Oya et al. (2013) Present work (2013)
Starting activity
11CO2 (EOB)
35 GBq 70 GBq 130 GBq 60.774 GBq
11CO2 trapping Liquid N2 cooling Carbosphere trap Carbosphere trap Carbosphere trap
Grignard reaction In-vial; EtMgBr in diethylether/THF 0.5 M/
0.4 mL
In-vial; EtMgBr/THF 250 mM/0.4 mL
THF, diethylether
In-vial; EtMgBr in diethylether /THF
0.5 M/0.4 mL
In-loop; EtMgBr/
THF (1M/1.5 mL)
Synthesis of acylation
reagents
Phthaloyl dichloride in THF (0.5 mL, 2M)
+DMF and 2,6-di-tert-butylpyridine; heated
to 130 1C and distilled
Phthaloyl dichloride in THF and 2,6-
di-tert-butylpyridine; heated to
170 1C and distilled
Phthaloyl dichloride (0.4 mL) and
2,6-di-tert-butylpyridine (0.3 mL),
distillation, Ar ﬂow
SOCl2/THF (5/
400 mL)
Acylation reaction Trapping 30 1C, 8 mmol HNO 50 ml THF,
50 mL diisopropylethyl-amine, 851C
Trapped 5 1C, 1–2 mg HNO 0.6 ml
THF 50 mL TEA, 80 1C
Trapped 5 1C, HNO in THF
Diisopropylethyl-amine, 80 1C
2.5 mg (+)-HNO
400 mL THF, 50 mL
TEA, 80 1C
Hydration 30 1C 1C, 0.6 mL 0.2N LiAlH4 in THF, 85 1C 15 1C, 0.1 mL 1M LiALH4 in THF
0.2 mL diethylether, 80 1C
0 1C, LiAlH4 in THF 15 1C, 0.52 1mL
LiAlH4 in THF , 80 1C
Quenching THF evaporation.1 mL HPLC solvent THF evaporation 1M HCl 2 M HCl THF evaporation,
0.8 mL 1M HCL
0.8 mL 1M NaOH
Puriﬁcation Semi-preparative HPLC, evaporation
and resolubilization
Semi-preparative HPLC, SPE Semi-preparative HPLC, SPE Semi-preparative
HPLC, SPE
Speciﬁc activity(EOS) 33–67 GBq/mmol 84737 GBq/mmol 18–91 GBq/mmol 140.6771 GBq/
mmol
RCY (EOS) 0.26–0.44 GBq 3.371.0 GBq 1.5–4.8 GBq 1.8370.55 GBq
Synthesis time 40 min 35.471.9 min 50–55 min 3772 min
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published data, all procedures lead to a suitable reaction outcome
for further use, but speciﬁc radioactivities achieved by loop-methods
are superior to those in “wet” methods. In-loop reactions for carbon-
11-labeled radioligands have been described for both 11C-methylations
(Gómez et al., 2008; Wilson et al., 2000, 2009; Iwata et al. 2001) and
11C-carboxylations using Grignard reactions (Arai et al., 2009; Courtyn
et al., 2001; Krasikova et al., 2003; Luthra et al., 1990; Matarrese et al.,
2002; McCarron et al., 1996; Zhang et al., 2006). We previously
published an in-loop set-up for the routine production of [carbo-
nyl-11C]WAY-100635 (Wadsak et al., 2007) which is still in use in our
facility in various clinical studies dealing with the (patho-)physiologi-
cal distribution of serotonin 5HT1A receptor, e.g. basic neuroscience
investigations (Hahn et al., 2012; Savli et al., 2012; Witte et al., 2009),
studies of several psychiatric disorders including major depression
(MDD) (Lanzenberger et al., 2012), anxiety disorders (Lanzenberger
et al., 2007; Spindelegger et al., 2009) and temporal lobe epilepsy
(Assem-Hilger et al., 2010).
Many other pharmacologically interesting compounds for neuro-
logical and psychiatric pathologies could also be obtained using such
a two-step synthesis route – ﬁrst a Grignard reaction and a
subsequent [11C]acylation. Among these compounds, especially, the
dopamine D2/3 receptor agonist [11C]-(+)-PHNO ([11C]-(+)-4-propyl-
3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol hydro-
chloride) is of interest. It was described as a superior PET-tracer for
the ﬂuctuations of synaptic dopamine (Narendran et al., 2006; Searle
et al., 2010; Shotbolt et al., 2012; Willeit et al., 2006). The radio-
synthesis of this 11C-compound was described in a challenging
procedure by Wilson et al. (2005) and, most recently, by Plisson
et al. (2012). The technical set-up using the proposed methods is very
demanding since it includes a distillation step for the puriﬁcation of
the intermediate 11C-acylating agent (see Table 1).
Since the in-loop method for 11C-carboxylation has originally
been implemented on site for the preparation of [carbonyl-11C]
WAY-100635 using a Nuclear Interface C11-methylation synthesizer
modiﬁcations were necessary to translate the set-up to the TRA-
CERlab FxC Pro platform now in use. Moreover, these modiﬁcations
should enable the implementation of a generalized in-loopsynthesis for 11C-carboxylations (Fig. 1). Its suitability was tested
in the preparation of both [11C]-(+)-PHNO and [carbonyl-11C]WAY-
100635 (Fig. 2).2. Materials and methods
2.1. General
Grignard reagents were purchased from Sigma Aldrich: ethylmag-
nesium bromide (3.0 M in diethylether, in Sure-Seal™), cyclohexyl-
magnesium chloride (2.0 M in diethyl ether) and methylmagnesium
bromide (3.0 M in diethylether in Sure-SealTM). Tetrahydrofurane (THF,
p.a., without stabilizing agent), thionyl chloride (SOCl2, 99%) and
triethylamine (TEA, 99.5%) were obtained from Sigma Aldrich (St.Louis,
MO, USA). Lithium aluminum hydride (LiAlH4, 1 M in THF) was
obtained from ABX (Advanced Biochemical Compounds, Radeberg,
Germany). 80 cm of a polyethylene (PE) tubing (Fine Bore Polythene
Tubing REF 800/100/280; ID: 0.86 mm OD: 1.52 mm, Smiths Medical
International Ltd., Kent, UK) was used as “Grignard loop” material.
Ascarite II, 20–30 mesh, was obtained from Thomas Scientiﬁc (Swe-
desboro, USA). Sterile water was purchased from Meditrade Medicare
Medizinprodukte (Kufstein, Austria). Solid phase extraction (SPE)
cartridges (SepPaks C18-plus) were obtained from Waters (Waterss
Associates Milford, MA, USA). 0.9% saline solution from B.Braun
(Melsungen, Germany), 3% saline solution from a local pharmacy
(Landesapotheke Salzburg, Austria), sodium dihydrogenphosphate-
monohydrate and disodiumhydrogenphosphate-dihydrate (both from
Merck, Darmstadt, Germany) were used for formulation of the
product. [11C]CO2 was produced in a GE PETtrace cyclotron (General
Electric Medical System, Uppsala, Sweden) via the 14N(p,α)11C nuclear
reaction by irradiation of a gas target (Aluminum) ﬁlled with N2 (+1%
O2) (Air Liquide Austria; irradiation parameters: 16 M eV protons,
10–25 mA h). Preparations were performed on the TRACERlab™ FX C
Pro synthesis platform (GE Healthcare, Uppsala, Sweden) including
semi-preparative HPLC, SPE puriﬁcation and product formulation.
Chemicals for preparative and analytical High Pressure Liquid Chro-
matography (HPLC) were obtained from Merck (Darmstadt, Germany)
Fig. 1. Illustration of synthesizer set-up adapted for in-loop 11C-carboxylations.
Fig. 2. Chemical Structure of [11C]-(+)-PHNO and [carbonyl-11C]WAY 100635.
n indicates the radioactive 11C atom.
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used without further puriﬁcation. Analytical radio-HPLC runs were
performed to verify product identity, to determine radiochemical
purity, and to quantify speciﬁc activity using a Merck-Hitachi LaChrom
system with a UV-detector and NaI-radio detector from Berthold
Technologies (Bad Wildbach, Germany).
2.2. Radiosyntheses
In-loop11C-carboxylation: 80 cm polyethylene (PE)-tubing was
coiled into a loop and equipped with two Luer-ﬁttings. Loops were
coated with a mixture of one of the three respective Grignard reagents
(500 mL) or diethyl ether (as negative control) in THF (1000 mL) for
comparison reasons. Therefore, the respective diluted Grignard solu-
tion was pushed through the loop and completely drained by a
smooth He-stream (5mL/min). (note: Grignard reagents were pur-
chased as solutions in diethyl ether). The inlet of the loop was
connected immediately after impregnation to the line from the
molecular sieve CO2 trap and the outlet to an Ascarite II trap to collect
unreacted [11C]CO2. Upon delivery from the cyclotron, [11C]CO2 was
transported to the hot cell and trapped on-line within the molecular
sieve. Subsequently, it was released by heating the trap to 400 1C andthe gas was passed to the previously impregnated loop using a smooth
stream of helium (3–5mL/min). Excess of unreacted [11C]CO2 (or not
combined 11C-intermediates) was retained within the Ascarite II trap.
The bound 11C-acylation synthon was swept out of the loop using a
mixture of THF (400 mL) and thionyl chloride (5 mL).
[Carbonyl-11C]WAY-100635: Precursor compound, WAY-100634,
and reference compound, WAY 100635, were obtained from ABX-
Advanced Biochemical Compounds (Radeberg, Germany). Semi-
preparative HPLC: column: Phenomenexs Gemini, 10 mm 110 A,
25010 mm2; mobile phase: methanol/0.1 M ammonium formate
(70/30) (v/v%) plus 3 mL TEA per liter; 8 mL/min; analytical HPLC:
column: Waterss m-Bondapak C-18 (5 mm, 3003.9 mm2 WAT0
27324) mobile phase: 0.1 M ammonium formate/ACN (55/45 v/v
%); 2 mL/min.
Up-scaled [carbonyl-11C]WAY-100635 production was performed
according to Wadsak et al. (2007) with modiﬁcations due to the
implementation of a new TRACERlab™ FX C pro synthesizer. Brieﬂy,
loop was coated by pushing a cyclohexane magnesium chloride
solution (0.5 mL) in THF (1 mL) through the PE-tubing equipped with
Luer-ﬁttings. Radioactivity was trapped nearly quantitatively and
converted on-line to magnesium chloride cyclohexane [11C]carboxy-
late. Using a thionyl chloride solution (5 mL in 400 mL THF), the
Grignard reaction intermediate was converted to the respective
carboxylic acid chloride, swept out the loop and transferred into the
reactor vial containing precursor (WAY-100634, 3.4–3.6 mg) in TEA
(20 mL) and THF (50 mL). Resulting reaction mixture was heated up to
70 1C for 4 min, cooled down to room temperature and quenched with
water (1 mL). Crude reaction mixture was automatically transferred
and injected to the semi-preparative HPLC system triggered by a ﬂuid
detector. Product peak was collected (6–8mL) and diluted (80 mL
water) within the bulb and passed through an SPE (C-18 plus) column.
After complete transfer, the column was washed with water (10 mL)
and the puriﬁed product was eluted with 1.5 mL ethanol and 5mL
Scheme 1. Radiosynthesis of [11C]PHNO
Table 2
In-loop trapping efﬁciency. 80 cm PE-Loops were coated with a mixture of the
respective Grignard reagents (500 mL containing ether)+THF (1000 mL). Calculated
percentages of radioactivity are referred to [11C]CO2 (¼100%) at EOB. Values are
given as arithmetic means7SD (nZ3; corrected for decay).
Trapping into loop
[%]
Release of 11C-acylation
synthon [%]
THF/ether 2.771.1 –
Methyl magnesium bromide 100 96.471.4
Ethyl magnesium bromide 100 98.972
Cyclohexane magnesium
chloride
100 98.972
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0.9%, 1 mL saline solution 3% and 1mL phosphate buffer (125 mM)
were added, transferred to a lead shielded laminar-air-ﬂow hot cell
and sterile-ﬁltered on-line.
[11C]-(+)-PHNO: Precursor compound, (+)-HNO hydrochloride,
and reference compound, (+)-PHNO, were obtained from ABX-
Advanced Biochemical Compounds (Radeberg, Germany). Semi-
preparative HPLC: column: Phenomenexs Luna C18(2), 10 mm,
25010 mm2; mobile phase: 25 mM PBS (pH 7.0)/acetonitrile
(ACN) (60/40 v/v%); 6 mL/min); analytical HPLC: LichroCARTs
Lichrospher 100, RP-18 (5 mm, 4250 mm2) with LichroCARTs
Lichrospher RP-18 guard column (5 mm, 44 mm2), mobile phase:
10 mM PBS (pH 7.0)/ACN (60/40 v/v%); 1.5 mL/min).
The [11C]-(+)-PHNO-radiosynthesis is outlined in Scheme 1. The
ﬁrst reaction step in the synthesis sequence, the Grignard reaction,
was performed on the basis of the previously described production
of [carbonyl-11C]WAY-100635 adopting the loop method. In this
case, the PE-loop was coated with ethyl magnesium bromide
(500 mL) in THF (1000 mL) for the conversion to magnesium bromide
[11C]propionate. Using thionyl chloride solution (5 mL in 400 mL
THF), the built [11C]propionic acid chloride was transferred directly
into the reaction vessel containing (+)-HNO (2.5 mg) suspended in
TEA (50 mL) and THF (400 mL). The resulting reaction mixture was
heated to 80 1C for 5 min. After cooling down to 15 1C, LiAlH4
(120 mL) in THF (400 mL) was added to the reaction intermediate
(i.e. [11C]1-((4αR,10βR)-9-hydroxy-5,6-dihydro-2H-naphtho[1,2-β]
[1,4]oxazin-4(3 H,4αH,10βH)-yl)propan-1-one) and subsequently
heated up to 80 1C for 2 min. Subsequently, THF was evaporated
completely within 2 min and the reaction mixture was cooled to
45 1C. Crude [11C]-(+)-PHNO was dissolved in 1 M HCl (800 mL) and
neutralized with 1 M sodium hydroxide solution (800 mL) prior to
injection onto semi-preparative HPLC. The HPLC fraction containing
puriﬁed [11C]-(+)-PHNO was collected (7–9 mL), diluted with water
(70 mL) and passed through a C-18 Sep-Paks plus cartridge. Further
workup procedure and formulation of the ﬁnal product were
identical to the described [carbonyl–11C]WAY-100635 method (see
above).3. Results and discussion
In-loop11C-carboxylation: 3 Grignard reagents were tested
regarding the trapping of [11C]CO2 and release of the respective
11C-acylation synthon (11C-carboxylic acid chloride). Release and
conversion was tested using thionyl chloride in THF for sweeping.
All Grignard reagents were able to trap irradiated [11C]CO2 nearlyquantitatively (Table 2). Using a mixture of THF and diethyl-ether
alone (i.e. without any Grignard reagent; “negative control”)
almost no trapping occurred (2.771.1% of initial radioactivity).
The release of radioactivity revealed minor differences within the
three tested Grignard reagents: [11C]propionic acid chloride and
cyclohexyl [11C]carboxylic acid chloride solution could be trans-
ferred to an extent of 98.972%. [11C]acetic acid chloride solution
contained 96.471.4% of the trapped radioactivity. Methyl magne-
sium bromide was chosen as additional Grignard reagent to test
whether the described method is able to guarantee reliable out-
come for further 11C-acylation synthons. Moreover, it might be
useful for the development of several radiotracers planned for
application in clinical trials in future.
[Carbonyl11C]WAY-100635: Overall synthesis outcome for the
modiﬁed routine-production set-up was 15.579.0% (3.472.1 GBq,
n¼22) (end of synthesis, EOS). The monitoring of the radioactivity
during the production process (Table 3) revealed that irradiated [11C]
CO2 was trapped nearly quantitatively within the impregnated loop
and 9872% (decay corrected) thereof were swept out using thionyl
chloride in THF. The routine procedure, including [11C]CO2 delivery,
carboxylation within the coated loop, acylation with precursor com-
pound (WAY-100634), HPLC and SPE puriﬁcation, formulation and
sterile ﬁltration, took 3173min in total. The ﬁnal product was
obtained in a total volume of 17.5 mL (containing 8.5% ethanol) as
sterile solution which always met the required quality parameters
(i.e. pH, osmolality, speciﬁc activity, precursor-content, radiochemical
and radionuclidic purity, absence of endotoxins, sterility) for human
application. Product identity, separation from precursor and speciﬁc
radioactivity were determined using analytical HPLC. Retention times
in the HPLC-analysis were 4.170.3 min (k′¼1.1670.15) for WAY-
100634 and 7.070.5 min (k′¼2.6870.27) for [carbonyl11C]WAY-
100635. Due to the implementation of a new synthesizer module
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CO2-trapping, as well as difﬁculties with the gas supplier at the time
of some of the experiments a wide deviation of speciﬁc radioactivity
(25–348 GBq/mmol) was observed.
[11C]-(+)-PHNO: In accordance to the experiences with [carbo-
nyl-11C]WAY-100635, the irradiated [11C]CO2 was trapped within the
ethyl magnesium bromide coated loop nearly quantitatively and could
be released by sweeping the loop with thionyl chloride to an extent of
9872%. During the 11C-acylation with the precursor compound,
(+)-HNO, about 10% of the radioactivity was lost. Reduction of the
intermediate, [11C]1-((4aR,10bR)-9-hydroxy-5,6-dihydro-2H-naphtho
[1,2-b][1,4]oxazin-4(3H,4aH,10bH)-yl)propan-1-one, with LiAlH4 could
be obtained in satisfying yields. Upon evaporation of the solvent THF,
59.179.6% of the initial radioactivity (at end of bombardement¼EOB)
were obtained after quenching with hydrochloric acid and neutraliza-
tion with 1 M NaOH. Radiochemical incorporation yields were mea-
sured in the diluted crude mixture and 22.8710.2% were obtained.
Retention times in the preparative HPLC-puriﬁcation were 3.17
0.2 min (k′¼0.4170.09) for (+)-HNO and 7.770.4 min (k′¼
2.5070.18) for [11C]-(+)-PHNO (Fig. 3). The product peak showed
high pH sensitivity regarding its retention time; therefore neutraliza-
tion of the crude mixture prior to HPLC puriﬁcation is mandatory.
Furthermore, three unknown (more hydrophilic) radioactive side-
products were observed within the preparative chromatogram of
the reaction solutions and could be separated from [11C]-(+)-PHNO
with retention times of 3.0570.1 min (k′¼0.3970.05), 3.557
0.1 min (k′¼0.6170.05) and 4.7070.2 min (k′¼1.1470.09). Similar
to the results with [carbonyl-11C]WAY-100635, speciﬁc activity wasFig. 3. Preparative HPLC Chromatogram of [1
Table 3
Progression of radioactivity during [11C]-(+)-PHNO synthesis and [carbonyl-11C]WAY-1
[11C]CO2 (¼100%). Values are given as arithmetic means7SD (nZ8; corrected for deca
[11C]-(+)-PHNO
Radioactivity (%) Duration (
Irradiation 100 (60.774.4 GBq) –
Carboxylation in loop and swept into reactor 98.972.0 7
Acylation – 5
Reduction with LiAlH4 90.0715.7 6
Dilution/addition of HCl 59.179.6 4
Loop waste/residue in the reactor 15.177.0 1
Preparative HPLC – 6
SPE, formulation, sterile ﬁltration – 7
Final product 8.274.2% –
(1.83 70.55 GBq)determined via analytical HPLC in a range of 57–305 GBq/mmol
(140.6771 GBq/mmol). Retention times in the respective assay were
2.170.1 min (k′¼0.3170.06) for (+)-HNO (precursor) and 5.27
0.2 min (k′¼2.2570.13) for [11C]-(+)-PHNO. Overall synthesis out-
come was 8.2574.2% (1.8370.55 GBq, range 1.16–3.0 GBq, n¼11;
end of synthesis, EOS) within 3772min. Time consumption is in a
comparable range to previously published synthesis procedures using
the distillation method for the separation of the 11C-acylating agent
(Plisson et al., 2012; Wilson et al., 2005). Initially, this distillation
method was used in a few syntheses but these were stopped since
constantly massive contaminations were observed within the hot-cell
environment. This was obviously due to the volatility of the trans-
ferred compounds and serious problems with leak tightness of the
system. Using the in-loop method – and therefore low amounts of
immobilized Grignard reagents – it was demonstrated that no
separation of excess Grignard intermediate from the crude product
was necessary.4. Conclusion
The set-up of a generalized in-loop method allows the reliable
11C-carboxylation in a rapid and feasible manner. Its general applic-
ability was demonstrated using three different Grignard compounds in
the present work. Modiﬁcations and implementation of this procedure
on a widely used (commercially available) synthesizer platform
was successful and straight forward. Subsequent conversion of the
11C-acylating agents without intermediate puriﬁcation was performed1C]PHNO and [carbonyl-11C]WAY100635.
00635. Calculated percentages of radioactivity are referred to initially irradiated
y).
[carbonyl-11C]WAY 100635
min) EOB (min) Radioactivity (%) Duration (min) EOB (min)
– 100 (55.378.1 GBq) – –
7 98.972.0 7 7
13 – 4 12
19 – – –
23 68.8710.5 2 14
24 11.776.0 1 15
30 – 8 23
37 – 8 31
3772 15.579.0% – 3173
(3.472.1 GBq)
C. Rami-Mark et al. / Applied Radiation and Isotopes 82 (2013) 75–8080for both [carbonyl-11C]WAY-100635 and [11C]-(+)-PHNO and revealed
high reliability and satisfactory outcome. In this work, we present data
on the ﬁrst [11C]-(+)-PHNO radiosynthesis comprising an in-loop
procedure yielding 8.2574.2% (1.8370.55 GBq, range 1.16–3.0 GBq,
n¼11; EOS) within 3772min. The presented methodmight be useful
also for future developments and its implementation in other PET
centers could help to widen the spectrum of available 11C-radiotracers.Acknowledgments
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